Aim: Although sexually transmitted viral infections are significant and increasing public health concern, little is known about their prevalence among Bulgarian women. The aim of this study was to investigate cervical viral infections in asymptomatic women.
INTRODUCTION
The incidence of viral sexually transmitted infections (STI) has increased considerably in recent years. Genital human papillomaviruses (HPV) are the most common STI and the main cause of cervical cancer. At the same time, most infections with HPV do not lead to cervical pathology. Therefore, it was suggested that additional co-factors, including co-infection with other sexually transmitted viruses, are required for progression of cervical HPV infection to cervical cancer. Some studies have shown that herpes simplex virus (HSV), cytomegalovirus (CMV), EpsteinBarr virus (EBV), human immunodeficiency virus (HIV) could be co-factors of HPV-associated carcinogenesis (1) (2) (3) . Although the majority of herpesvirus infections in women are asymptomatic, these viruses could be responsible for clinically apparent genital infections, sometimes leading to complications, such as endometritis, pelvic inflammatory disease and salpingitis. HIV and some members of herpesvirus family are major cause of congenital or neonatal infections. Although viral STI are a significant and increasing public health concern, relatively little is known about their prevalence among Bulgarian women. The purpose of this study was to determine the prevalence of HPV, HSV types 1 and 2, CMV, EBV and HIV in cervical specimens, obtained from asymptomatic Bulgarian women.
MATERIALS AND METHODS

Study Participants
The study involved 52 randomly selected asymptomatic female volunteers from Bulgarian border town Kardzhali of median age 39 years (range 17-57 years). They were asked to complete a standard questionnaire to collect data on demographics, reproductive health, cervical cancer screening history, use of contraceptives, and smoking status. The basic characteristics of the study group are shown in Table 1 . Informed consent for participation in the study was obtained from all participants. The study protocol was approved by the Ethical Committee at the Bulgarian Medical Association, Kardzhali Region (Approval No. 02/03.05.2013). Cervical specimens were taken from all women by cytobrush and collected in PreservCyt solution (Hologic) for virological investigations.
Nucleic Acid Extraction
The virus DNA and RNA were extracted from cervical specimens using MicroElute Viral RNA/DNA extraction kit (Cat. No: R6974-01, Omega Bio-tek USA) and DNA-sorb-B nucleic acid extraction kit (Cat. No: K1-2-100-CE, Ecoli, Bratislava, Slovak Republic) according to the instructions provided by the manufacturers. 
Real-time PCR Amplification
RESULTS
Fifty-two cervical specimens, obtained from asymptomatic women from Bulgarian border town Kardzhali, were analysed by RT PCR to assess the presence of high-and low-risk HPV, HSV types 1 and 2, CMV, EBV and HIV. Our results showed that 32 (61.5%) women were infected with one or more viruses. Of all 52 studied samples 17 (32.7%) were positive for HPV (HR and/ or LR), 16 (30.8%) were HSV1 and 2 positive, 5 (9.6%), and 3 (5.8%) samples were positive for EBV and CMV, respectively. None of the cervical samples were HIV positive. HPV prevalence among women aged 35 or younger was about 2.5 times higher than in older women. EBV and CMV were found only in cervical samples obtained from women older than 35 years. HSV prevalence was similar in both age groups. Most of the women were HSV1 infected, HSV2 was detected in only one cervical sample (Table 2) .
Multiple infections were detected in 9 (28%) of 32 positive women. Most of them (8 samples 5 samples (N = 52, 9.6%; N = 17, 29.4%), followed by HPV31, HPV 51 and HPV56 detected in 2 samples each (N = 52, 3.8%; N = 17, 11.8%), and HPV18, HPV 52 and HPV 59 in one sample each (N = 52, 1.9%; N = 17, 5.9%) ( Table 3) . We were not able to determine any genotype in one HR HPV positive sample. HPV11, HPV33, HPV35, HPV39, HPV45 and HPV58 were not found. In 5 specimens (N = 52, 9.6%; N = 17, 29.4%) we detected co-infection with two HPV genotypes -four HR/HR genotypes and one HR/LR genotype.
DISCUSSION
In current study we demonstrated that 61.5% of cervical samples obtained from participating women were infected with one or more viruses. The most prevalent was HPV, found in 32.7% of all women. As the study group is considered at low risk (small town, older age, majority of women are married, etc.) it is not surprising that the overall HPV positivity among these women is lower than that previously detected in a high risk group of female sex workers (43.4%) (4) . At the same time, the HPV positivity in our study was about 2.5 times higher than the mean HPV prevalence among women from Central and Eastern Europe with normal cervical cytology (12.6%), indicating a higher risk of cervical cancer (5) . In accordance with previous data we found that younger women (age group ≤ 35) were about 2.5 times more infected and that HPV16 was the most frequently (9.6%) detected HR genotype among all women. We observed a very high prevalence of HPV6 (13.5%).
HIV was not detected in any of cervical samples and this was not surprising given the low HIV positivity in the country. The overall HSV1/2 prevalence (30.8%) in our study was almost as high as that of HPV. Moreover, the number of herpesvirus infected women in our study is most likely even higher, because as it is known from the literature, not all infected individuals shed the virus in their genital tract. The prevalence of HSV demonstrated in this study was higher than that previously described in cervical samples from other countries. Several studies investigated asymptomatic HSV shedding from the uterine cervix by PCR -the lowest rates (approximately 3%) were observed in Turkey and Sweden and the highest in Argentina (21.5%) and Brazil (26%) (6) (7) (8) (9) . It was interesting that most cases in our study were HSV1 positive and only one was HSV2 positive. Although HSV2 is considered one of the most common cause of genital ulceration, many studies indicate an increase in genital herpes caused by HSV1 (10-15). Our results support this trend. The high HSV positivity we observed in this study was in accordance with a previous seroepidemiological study of HSV1 and 2 in several European countries -the highest rates were found in Bulgaria (16) . This is quite disturbing as HSV is implicated as an important cofactor of HPV infection and HPV-related cervical carcinogenesis (2) . Bulgaria is one of the European countries with the highest incidence and mortality of cervical cancer (17) , and it is possible that the high prevalence of genital HSV infection contributes to this situation.
Overall 9.6% and 5.8% of women in our study group were infected with EBV and CMV, respectively. Worldwide, EBV and CMV cervical positivity ranges from 2.6% to 40% and from 1.4% to 66%, respectively (7, 9-10, 18, 19) . Most of these studies utilized in-house PCR for identification of EBV and CMV. It is possible that methodological issues, such as PCR protocols or difference in sensitivity of PCR systems used for virus detection, may contribute to the observed variation of EBV/CMV prevalence in cervical samples between studies. In addition, this variation could be due to other factors -differences in sexual behaviour, geographical origin etc. According to the literature the highest rates of CMV (66%) and EBV (40%) cervical positivity were found among women with normal cervical smears attending cervical screening programme in Monza (Italy) and Aberdeen (UK), respectively (19, 20) .
According to some previous studies EBV infection is more frequent in older women, but CMV prevalence decreases with age (18, 21) . In our case EBV and CMV infections were found only in women older than 35 years. Our findings support the previous data concerning EBV and CMV cervical shedding and possibility of sexual transmission (22) . It is not quite clear what is the clinical significance of these infections, including their role in cervical carcinogenesis. At the same time, EBV-associated genital ulcers in women have been previously reported (23, 24) and although CMV is not common cause of cervicitis, it is known as an important cause of congenital infection.
In conclusion, this investigation demonstrates a high rate of infection of uterine cervix with one or more viruses in participating women considered at low risk. Our results indicate that there is a high risk for genital pathology, including cervical cancer, and for transmission of virus infection sexually and perinatally. As far Table 3 . Prevalence of HPV genotypes as we know, these are the first data for Bulgaria concerning HSV, EBV, CMV and HIV detection in cervical specimens and potential co-infection of these viruses with HPV. At the same time, there are some limitations of this study. Because the size of study group is small and all women come from one place, it is impossible to draw conclusions from these findings about Bulgarian women in general. In addition, given the cross-sectional nature of our study, the data do not exclude the possibility of spontaneous clearance of some of virus infections detected in this survey. Further, we do not know what would be the consequences for infected women in the future. Nevertheless, our findings could raise awareness and contribute to early recognition of these infections, initiation of effective treatment and prevention strategies as well as to further surveys involving larger groups of women.
